Nov20

Amazon-Berkshire-JPM venture recruits health insurance executive

Dana Gelb Safran, a Blue Cross Blue Shield of Massachusetts executive who works on analytics and improving outcomes, will serve as the initiative’s “head of measurement,” according to CNBC.

Nov20

Report: Walgreens and Humana looking to take equity stakes in each other

The two companies are already working together on a pilot program putting senior-focused primary care centers in Walgreens stores located in Kansas City.

Nov20

Exclusive: Los Angeles startup Heal expands health and wellness services for children and new mothers

Heal eventually want to cover everything from pre-birth services like lactation consulting, to vaccinations and immunizations and on through mental and sexual health as the child gets older.

Nov20

Three PD-L1 inhibitors see setbacks in their development

Two drugs – Pfizer and Merck KGaA’s Bavencio and AstraZeneca’s Imfinzi – saw Phase III trials fail, while anticipated negative results prompted Roche to withdraw Tecentriq from regulatory review.

Nov20

One Medical CTO discusses company’s tech initiatives

In a phone interview, One Medical CTO Kimber Lockhart talked about how the company has developed its own EHR and mobile app.

Nov20

Pfizer to raise prices on 41 drugs despite earlier deferral on price hikes

The company emphasized that the increases mostly amount to 3-5 percent and affect only 10 percent of its portfolio, but declined to reveal which drugs are affected.

Nov20

Big data and big pharma giants join forces on cancer research effort

Merck and Palantir Technologies are forming a joint research venture called Syntropy as a way to offer data analytics tools to healthcare organizations.

Nov20

Renalytix AI raises $29M through IPO for AI-based kidney disease diagnostics

The company’s first product, a diagnostic aid known as KidneyIntelX is aiming to identify patients at risk for particularly fast progression of kidney disease.